Pfizer Drops $118 Billion AstraZeneca Bid As Time Runs Out

By Kerry Benn (May 26, 2014, 11:37 AM EDT) -- Pfizer Inc. said Monday it will no longer pursue its sweetened £69.4 billion ($118 billion) offer for rival drug maker AstraZeneca plc, which kept up its stiff opposition to the bid even as it ran up against the end of the deadline period mandated by U.K. takeover rules....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!